Vitamin D modulates biliary fibrosis in ABCB4-deficient mice
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
PURPOSE: Impaired vitamin D receptor signaling represents an aggravating factor during liver injury, and recent studies suggest that vitamin D might exert a protective role in chronic hepatobiliary diseases. We hypothesized that vitamin D supplementation would ameliorate liver fibrosis in ATP-binding cassette transporter B4 knockout (Abcb4 (-/-)) mice as a preclinical model of sclerosing cholangitis. METHODS: Abcb4 (-/-) and wild-type mice were fed a regular chow diet (600 IU vitamin D/kg food) or diets with lower (100 IU/kg) and higher (2,400 IU/kg) vitamin D concentrations for 12 weeks. Serum 25-hydroxyvitamin D concentrations were measured by chemiluminescence immunoassays. Liver injury and biliary fibrosis were assessed by liver enzyme activities, histopathology and hepatic collagen contents. Hepatic mRNA expression of markers for fibrosis, vitamin D and bile acid metabolism were analyzed by quantitative PCR. RESULTS: Different vitamin D concentrations were observed depending on genotype and diet group, with Abcb4 (-/-) mice on the control diet showing lower vitamin D concentrations compared to wild-type mice. Abcb4 (-/-) animals on the low vitamin D diet demonstrated the most advanced liver fibrosis and highest hepatic collagen contents. Feeding Abcb4 (-/-) mice a high vitamin D diet enriched serum vitamin D levels, lowered liver enzyme activities, altered expression levels of profibrogenic genes and ameliorated, in part, liver injury. CONCLUSIONS: This is the first report to demonstrate that fibrogenesis in the established Abcb4 (-/-) model is influenced by vitamin D supplementation. Since vitamin D modulates sclerosing cholangitis in vivo, we speculate that sufficient vitamin D intake might improve liver damage and induce antifibrotic effects in chronic cholestasis in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Results from other studies further support the protective role of Vitamin D and VDR activation against hepatic fibrosis, evidenced by a reduction of hydroxyproline levels and decreased expression levels of pro-fibrogenic genes (e.g., col1α1 and tissue inhibitor of metalloproteinase-1 (TIMP-1)) in Mdr2 -/-mice after supplementation of Vitamin D. [98]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [98]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Histological grading and staging of chronic hepatitis
Ishak, K., Baptista, A., Bianchi, L., Callea, F., De Groote, J., Gudat, F., Denk, H., Desmet, V., Korb, G., MacSween, R. N. M., et al. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80226-6 · Cited by 5,029 · cited 1×
“Hepatic fibrosis was staged (F-score) using a scale adapted from the Batts and Ludwig as well as Ishak scoring systems [22, 23].”
MethodBataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
Bataller, R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524282c1 · Cited by 1,472
Vitamin D Receptor As an Intestinal Bile Acid Sensor
Makishima, M., Lu, T. T., Xie, W., Whitfield, G. K., Domoto, H., Evans, R. M., Haussler, M. R., & Mangelsdorf, D. J. (2002) · Science · doi:10.1126/science.1070477 · Cited by 1,176
Gombart, A. F., Borregaard, N., & Koeffler, H. P. (2005) · The FASEB Journal · doi:10.1096/fj.04-3284com · Cited by 1,136
An Update on Terminology and Reporting
Batts, K. P., & Ludwig, J. (1995) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199512000-00007 · Cited by 1,080 · cited 1×
“Hepatic fibrosis was staged (F-score) using a scale adapted from the Batts and Ludwig as well as Ishak scoring systems [22, 23].”
MethodPálmer, H. G., González-Sancho, J. M., Espada, J., Berciano, M. T., Puig, I., Baulida, J., Quintanilla, M., Cano, A., de Herreros, A. G., Lafarga, M., et al. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200102028 · Cited by 802
Bile acids as regulatory molecules
Hylemon, P. B., Zhou, H., Pandak, W. M., Ren, S., Gil, G., & Dent, P. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r900007-jlr200 · Cited by 694 · cited 1×
“VDR, FXR and PXR [35–38].”
Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier
Kong, J., Zhang, Z., Musch, M. W., Ning, G., Sun, J., Hart, J., Bissonnette, M., & Li, Y. C. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00398.2007 · Cited by 667 · cited 1×
“Since vitamin D has been shown to be involved in the regulation of apical junctional complexes in other organs [43–45], Firrincieli et al.”
Where is the vitamin D receptor?
Wang, Y., Zhu, J., & DeLuca, H. F. (2012) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2012.04.001 · Cited by 629
A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response
Ding, N., Yu, R. T., Subramaniam, N., Sherman, M. H., Wilson, C., Rao, R., Leblanc, M., Coulter, S., He, M., Scott, C., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.028 · Cited by 622 · cited 2×
“Recently, elegant mechanistic studies have demonstrated that the activation of VDR antagonizes TGF-binduced recruitment of SMAD3 via co-occupation of regulatory sites in key profibrogenic genes (including COL1A2, TIMP1 and TGFB1) in the presence of TGF-b [31].”
BackgroundA simple method to determine nanogram levels of 4-hydroxyproline in biological tissues
Jamall, I. S., Finelli, V. N., & Que Hee, S. S. (1981) · Analytical Biochemistry · doi:10.1016/0003-2697(81)90261-x · Cited by 518 · cited 1×
“In addition, collagen in liver was quantified by colorimetric measurement of the collagen-specific amino acid hydroxyproline, as described previously [24, 25].”
MethodFickert, P., Fuchsbichler, A., Wagner, M., Zollner, G., Kaser, A., Tilg, H., Krause, R., Lammert, F., Langner, C., Zatloukal, K., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.04.009 · Cited by 468 · cited 3×
“Distinct functional and morphological alterations of these junctional complexes have been described in cholestasis in both mice and humans [19, 42].”
BackgroundMethodSelf-citationPetta, S., Cammà, C., Scazzone, C., Tripodo, C., Di Marco, V., Bono, A., Cabibi, D., Licata, G., Porcasi, R., Marchesini, G., et al. (2010) · Hepatology · doi:10.1002/hep.23489 · Cited by 448
Th, M., van Nieuwkerk, C. M., Dingemans, K. P., Smit, J. J., Schinkel, A. H., Notenboom, R. G. E., Weerman, M. A. V. D. B., VERKRUISEN, R. P., Groen, A. K., & Elferink, R. P. J. O. (1994) · PubMed · Cited by 403
Prevalence of Vitamin D Deficiency in Chronic Liver Disease
Arteh, J., Narra, S., & Nair, S. (2010) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-1069-9 · Cited by 394 · cited 1×
“These observations are relevant for future translational studies, because chronic cholestatic liver injury in humans is frequently accompanied by vitamin D deficiency [7, 28].”
BackgroundFickert, P., Wagner, M., Marschall, H., Fuchsbichler, A., Zollner, G., Tsybrovskyy, O., Zatloukal, K., Liu, J., Waalkes, M. P., Cover, C., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.10.018 · Cited by 300 · cited 1×
“Hence, we hypothesized that vitamin D supplementation ameliorates liver fibrosis in vivo by phenotyping Abcb4 (ATP-binding cassette transporter, subfamily B, member 4) knockout (Abcb4, also known as Mdr2) mice, an established and highly reproducible model of sclerosing cholangitis [16–18].”
Self-citationAbramovitch, S., Dahan-Bachar, L., Sharvit, E., Weisman, Y., Tov, A. B., Brazowski, E., & Reif, S. (2011) · Gut · doi:10.1136/gut.2010.234666 · Cited by 286 · cited 1×
“On the other hand, in vitro studies and a rat model of toxin-induced hepatic fibrosis have demonstrated possible antifibrotic effects of vitamin D supplementation through diminished hepatic stellate cell (myofibroblast) activation and collagen expression [29–31].”
Gascon-Barré, M., Demers, C., Mirshahi, A., Néron, S., Zalzal, S., & Nanci, A. (2003) · Hepatology · doi:10.1053/jhep.2003.50176 · Cited by 254 · cited 1×
“In the liver, VDR expression is restricted to non-parenchymal cells and biliary epithelial cells [11].”
BackgroundOhyama, Y., Ozono, K., Uchida, M., Shinki, T., Kato, S., Suda, T., Yamamoto, O., Noshiro, M., & Kato, Y. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34094-2 · Cited by 231
Vitamin D and Parathyroid Hormone in Outpatients With Noncholestatic Chronic Liver Disease
Fisher, L., & Fisher, A. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.10.015 · Cited by 222 · cited 1×
“investigated the beneficial and adverse effects of vitamin D supplementation in chronic liver diseases [7–9].”
D'Aldebert, E., Biyeyeme Bi Mve, M., Mergey, M., Wendum, D., Firrincieli, D., Coilly, A., Fouassier, L., Corpechot, C., Poupon, R., Housset, C., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.12.040 · Cited by 219
Regulation of Bile Acid Synthesis by Fat-soluble Vitamins A and D
Schmidt, D. R., Holmstrom, S. R., Fon Tacer, K., Bookout, A. L., Kliewer, S. A., & Mangelsdorf, D. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.116004 · Cited by 213
Vitamin D in chronic liver disease
Stokes, C. S., Volmer, D. A., Grünhage, F., & Lammert, F. (2013) · Liver International · doi:10.1111/liv.12106 · Cited by 194 · cited 1×
“Vitamin D is a steroid hormone with pleiotropic effects that undergoes hydroxylation in liver and kidney [6].”
BackgroundSelf-citationLithocholic Acid Feeding Induces Segmental Bile Duct Obstruction and Destructive Cholangitis in Mice
Fickert, P., Fuchsbichler, A., Marschall, H.-U., Wagner, M., Zollner, G., Krause, R., Zatloukal, K., Jaeschke, H., Denk, H., & Trauner, M. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.050404 · Cited by 188 · cited 1×
“CK19 was detected using a monoclonal rabbit anti-Troma-III antibody (1:500) [27].”
MethodSelf-citationNuclear receptors in bile acid metabolism
Li, T., & Chiang, J. Y. L. (2013) · Drug Metabolism Reviews · doi:10.3109/03602532.2012.740048 · Cited by 176 · cited 1×
“VDR, FXR and PXR [35–38].”
Moustafa, T., Fickert, P., Magnes, C., Guelly, C., Thueringer, A., Frank, S., Kratky, D., Sattler, W., Reicher, H., Sinner, F., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.09.051 · Cited by 163 · cited 1×
“Hence, we hypothesized that vitamin D supplementation ameliorates liver fibrosis in vivo by phenotyping Abcb4 (ATP-binding cassette transporter, subfamily B, member 4) knockout (Abcb4, also known as Mdr2) mice, an established and highly reproducible model of sclerosing cholangitis [16–18].”
Self-citationLammert, F., Wang, D. Q.-H., Hillebrandt, S., Geier, A., Fickert, P., Trauner, M., Matern, S., Paigen, B., & Carey, M. C. (2004) · Hepatology · doi:10.1002/hep.20022 · Cited by 159
Self-citationTrépo, E., Ouziel, R., Pradat, P., Momozawa, Y., Quertinmont, E., Gervy, C., Gustot, T., Degré, D., Vercruysse, V., Deltenre, P., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.03.024 · Cited by 140 · cited 1×
“Moreover, in these patients, low vitamin D levels are associated with increased grades of necroinflammation and stages of fibrosis and a heightened mortality risk [3–6].”
A Novel Bile Acid-Activated Vitamin D Receptor Signaling in Human Hepatocytes
Han, S., Li, T., Ellis, E., Strom, S., & Chiang, J. Y. L. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0482 · Cited by 137
Putz‐Bankuti, C., Pilz, S., Stojakovic, T., Scharnagl, H., Pieber, T. R., Trauner, M., Obermayer‐Pietsch, B., & Stauber, R. E. (2012) · Liver International · doi:10.1111/j.1478-3231.2011.02735.x · Cited by 127 · cited 1×
“Moreover, in these patients, low vitamin D levels are associated with increased grades of necroinflammation and stages of fibrosis and a heightened mortality risk [3–6].”
Dhawan, P., Peng, X., Sutton, A. L. M., MacDonald, P. N., Croniger, C. M., Trautwein, C., Centrella, M., McCarthy, T. L., & Christakos, S. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.25.1.472-487.2005 · Cited by 105 · cited 1×
“Vitamin D levels are regulated through degradation via 24-hydroxylase, and vitamin D induces the expression of this enzyme, thus controlling its own catabolism [33, 34].”
BackgroundSakisaka, S., Kawaguchi, T., Taniguchi, E., Hanada, S., Sasatomi, K., Koga, H., Harada, M., Kimura, R., Sata, M., Sawada, N., et al. (2001) · Hepatology · doi:10.1053/jhep.2001.25086 · Cited by 105 · cited 1×
“Distinct functional and morphological alterations of these junctional complexes have been described in cholestasis in both mice and humans [19, 42].”
BackgroundHillebrandt, S., Goos, C., Matern, S., & Lammert, F. (2002) · Gastroenterology · doi:10.1053/gast.2002.37069 · Cited by 104
Self-citationChow, E. C. Y., Magomedova, L., Quach, H. P., Patel, R., Durk, M. R., Fan, J., Maeng, H., Irondi, K., Anakk, S., Moore, D. D., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.12.027 · Cited by 90 · cited 1×
“VDR, FXR and PXR [35–38].”
Gniadecki, R. (1997) · Endocrinology · doi:10.1210/en.138.6.2241 · Cited by 84
van Nieuwerk, C. M. J., Groen, A. K., Ottenhoff, R., van Wijland, M., Weerman, M. A. V. D. B., Tytgat, G. N. J., Offerhaus, G. J. A., & Elferink, R. P. J. O. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80020-7 · Cited by 81 · cited 1×
“fibrogenesis in ABCB4-deficient mice [39], although the expression of the genes encoding the rate-limiting enzymes for bile salt synthesis (Cyp7a1) and conversion to the hydrophobic cholic acid (Cyp8b1) showed no major differences across the groups.”
BackgroundCommon genetic variation in vitamin D metabolism is associated with liver stiffness
Grünhage, F., Hochrath, K., Krawczyk, M., Höblinger, A., Obermayer-Pietsch, B., Geisel, J., Trauner, M., Sauerbruch, T., & Lammert, F. (2012) · Hepatology · doi:10.1002/hep.25830 · Cited by 71
Self-citationLithocholic acid downregulates vitamin D effects in human osteoblasts
Ruiz‐Gaspà, S., Guañabens, N., Enjuanes, A., Peris, P., Martinez‐Ferrer, A., Martinez de Osaba, M. J., Gonzalez, B., Alvarez, L., Monegal, A., Combalia, A., et al. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02230.x · Cited by 70 · cited 1×
“VDR, FXR and PXR [35–38].”
The estimated benefits of vitamin D for Germany
Zittermann, A. (2010) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200900494 · Cited by 68 · cited 1×
“Vitamin D deficiency occurs in up to 90 % of patients with chronic liver diseases, irrespective of the underlying etiology of liver injury [1, 2].”
BackgroundInhibition of LXRα signaling by vitamin D receptor: Possible role of VDR in bile acid synthesis
Jiang, W., Miyamoto, T., Kakizawa, T., Nishio, S., Oiwa, A., Takeda, T., Suzuki, S., & Hashizume, K. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.027 · Cited by 66 · cited 1×
“Furthermore, regulation of bile acid synthesis and enzymes responsible for bile acid detoxification are influenced by vitamin D-VDR-signaling [13–15].”
Potter, J. J., Liu, X., Koteish, A., & Mezey, E. (2013) · Liver International · doi:10.1111/liv.12122 · Cited by 63
Osteomalacia, Vitamin D Deficiency and Cholestasis in Chronic Liver Disease
(1982) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a067709 · Cited by 61 · cited 1×
“These observations are relevant for future translational studies, because chronic cholestatic liver injury in humans is frequently accompanied by vitamin D deficiency [7, 28].”
BackgroundFirrincieli, D., Zúñiga, S., Rey, C., Wendum, D., Lasnier, E., Rainteau, D. P., Braescu, T., Falguières, T., Boissan, M., Cadoret, A., et al. (2013) · Hepatology · doi:10.1002/hep.26453 · Cited by 55
Status of research on vitamin D supplementation in treating or preventing liver fibrosis
Song, B., & Rockey, D. C. (2013) · Liver International · doi:10.1111/liv.12147 · Cited by 24 · cited 1×
“investigated the beneficial and adverse effects of vitamin D supplementation in chronic liver diseases [7–9].”
Research works printed but not linked: 1
- National Research Council. Nutrient Requirements of Laboratory Animals, Fourth Revised Edition, Washington, DC: The National Academies Press; 1995. 80–102
Cited by
New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond
Beuers, U., Trauner, M., Jansen, P., & Poupon, R. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.023 · Cited by 537
“The anti-fibrotic potential of VDR stimulation has been demonstrated in several models of liver fibrosis, among them the Mdr2 (Abcb4) / mice [192,193].”
BackgroundPrimary biliary cholangitis: pathogenesis and therapeutic opportunities
Gulamhusein, A. F., & Hirschfield, G. M. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0226-7 · Cited by 308
Variants in ABCB4 (MDR3) across the spectrum of cholestatic liver diseases in adults
Stättermayer, A. F., Halilbasic, E., Wrba, F., Ferenci, P., & Trauner, M. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.04.036 · Cited by 113
The role of vitamin D and vitamin D binding protein in chronic liver diseases
Pop, T. L., Sîrbe, C., Benţa, G., Mititelu, A., & Grama, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810705 · Cited by 105
“Vitamin D administration reduces extracellular matrix deposition and attenuates fibrosis in animal models of chronic hepatic injury [16,54,59], but the ability to remediate already-established fibrosis is less promising.”
BackgroundJaved, Z., Papageorgiou, M., Deshmukh, H., Kilpatrick, E. S., Mann, V., Corless, L., Abouda, G., Rigby, A. S., Atkin, S. L., & Sathyapalan, T. (2019) · Nutrients · doi:10.3390/nu11010188 · Cited by 99
Metadata
- Authors
- Hochrath, K., Stokes, C. S., Geisel, J., Pollheimer, M. J., Fickert, P., Dooley, S., & Lammert, F.
- Affiliations
- Saarland University (DE)
- Universitätsklinikum des Saarlandes (DE)
- Medical University of Graz (AT)
- Heidelberg University (DE)
- Corresponding author
- Lammert, Frank
- Venue
- Hepatology International
- Published
- 2014-06-21
- Volume
- 8
- Issue
- 3
- Pages
- 443-452
- ISSN
- 1936-0533 (ISSN-L)
- 1936-0541
- PMC
- PMC4148166
- OpenAlex
- W2011489820
- Cited by
- 36
- References
- 46
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 3 · 2023: 1 · 2022: 5 · 2021: 3 · 2020: 4 · 2019: 6 · 2018: 2 · 2017: 3 · 2016: 2 · 2015: 4
- FWCI
- 1.56
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Hepatology International (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (SFB‐TRR57, SFB/TRR57 TP01, DFG: SFB/TRR57)
- Rheinische Friedrich-Wilhelms-Universität Bonn
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
- Keywords
- vitamin D, biliary fibrosis, sclerosing cholangitis, ABCB4, Abcb4 knockout mice, vitamin D receptor signaling, liver fibrosis, chronic cholestasis, bile acid metabolism, hepatic collagen, vitamin D supplementation, antifibrotic effect
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.